Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Opyl Limited (OPL.AX)

Compare
0.0310
0.0000
(0.00%)
At close: April 1 at 11:24:13 AM GMT+11
Loading Chart for OPL.AX
  • Previous Close 0.0310
  • Open 0.0310
  • Bid 0.0270 x --
  • Ask 0.0300 x --
  • Day's Range 0.0310 - 0.0310
  • 52 Week Range 0.0140 - 0.0330
  • Volume 25,000
  • Avg. Volume 138,718
  • Market Cap (intraday) 5.982M
  • Beta (5Y Monthly) 1.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

www.opyl.ai

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: OPL.AX

View More

Performance Overview: OPL.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

OPL.AX
63.16%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

OPL.AX
24.00%
S&P/ASX 200 [XJO] (^AXJO)
1.36%

3-Year Return

OPL.AX
57.47%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

OPL.AX
42.29%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: OPL.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OPL.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    5.98M

  • Enterprise Value

    6.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    31.06

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    31.01

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -296.24%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    196.09k

  • Net Income Avi to Common (ttm)

    -2.54M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    329.55k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.18M

Research Analysis: OPL.AX

View More

Company Insights: OPL.AX

Research Reports: OPL.AX

View More

People Also Watch